Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2003
09/09/2003US6616893 Especially for diagnosis of pregnancy or drug use
09/09/2003US6616820 Exhaust species sensing method and device
09/09/2003US6616819 Small volume in vitro analyte sensor and methods
09/09/2003US6615791 Modular internal combustion engine
09/09/2003US6615661 Ultrasound sorting of weanling calves and identification of tenderness indicators
09/09/2003US6615653 In situ method for determining soil liquefaction tendency and its prevention by electro-osmosis
09/09/2003US6615646 Carbon dioxide sensor for controlling exhaust gas recirculation in diesel engines
09/09/2003US6615643 Systems and methods for determining the absorption and specific gravity properties of compacted and loose material including fine and coarse aggregates
09/09/2003US6615592 Method and system for preparing tissue samples for histological and pathological examination
09/09/2003CA2300261C Method for selectively harvesting vegetable raw material from a sphagnum moss
09/09/2003CA2142121C Effects of actin filaments on fibrin clot structure and lysis
09/09/2003CA2112875C Analytical method for nonmetallic contaminants in silicon
09/09/2003CA2108282C Quantitative clotting assay for activated factor vii
09/09/2003CA2089870C Immunological test for the presence of antibodies in biological fluids, and a kit for carrying out the test
09/09/2003CA2083313C Colorimetric methods and reagents for the assay of calcium in a test sample
09/09/2003CA2062105C Purified mite allergen
09/07/2003WO2003074701A1 p18AβrP GENE AND p18AβrP PROTEIN, NOVEL GENE/PROTEIN (p60TRP) INTERACTING THEREWITH TO INHIBIT CELL DEATH AND CELL DEATH PROMOTER
09/07/2003CA2432937A1 P18abrp gene and p18abrp protein, and novel gene/protein (p60trp) suppressing cell death and substances promoting cell death by interaction with the same
09/06/2003CA2421134A1 Method and kit for measuring skin inflammation or irritation
09/04/2003WO2003073444A1 Fe/au nanoparticles and methods
09/04/2003WO2003073355A2 Method and apparatus for generating chemical reaction transforms
09/04/2003WO2003073351A2 Screening process
09/04/2003WO2003073350A2 Method and analytical system for identifying targets in a signaling network
09/04/2003WO2003073238A2 Computational method for designing enzymes for incorporation of amino acid analogs into proteins
09/04/2003WO2003073233A2 Sequence detection system calculator
09/04/2003WO2003073135A1 A method and apparatus for quantifying progress of sample clean up with curve fitting
09/04/2003WO2003073107A2 Neuropeptide receptor and uses thereof
09/04/2003WO2003073106A2 Binding of pathological forms of prion proteins
09/04/2003WO2003073105A2 Use of plag1 and plagl2 in cancer diagnosis and drug screening
09/04/2003WO2003073104A2 Diagnostic and therapeutic use of ma onconeuronal antigens for neurodegenerative diseases
09/04/2003WO2003073103A1 Method for detecting diseases that are associated with defects of cystic fibrosis transmembrane conductance regulator (cftr) protein
09/04/2003WO2003073102A1 Method of diagnosing adolescent idiopathic scoliosis and related syndromes
09/04/2003WO2003073101A2 Mycobacterial proteins as early antigens for serodiagnosis and vaccines
09/04/2003WO2003073099A1 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome
09/04/2003WO2003073098A1 Method of screening psychotropic
09/04/2003WO2003073095A1 Instrument for separating plasma or serum, method of collecting plasma or serum, method of separating plasma or serum, test carrier and glass fiber
09/04/2003WO2003073091A1 Measurement instrument
09/04/2003WO2003073090A1 Measurement instrument, measurement tool storage case and operation mechanism
09/04/2003WO2003073081A2 Apparatus and method for detecting fecal and ingesta contamination on hands using an illumination imaging device
09/04/2003WO2003073080A1 Apparatus and method for detecting fecal and ingesta contamination using a hand held illumination and imaging device
09/04/2003WO2003073075A2 Method for the analysis of lubricant basicity
09/04/2003WO2003073068A2 Population based assessments and means to rank the relative immunogenicity of proteins
09/04/2003WO2003073065A2 Molecular diagnosis and prognosis of carcinomas
09/04/2003WO2003073063A2 Modulating insulin receptor signaling through targeting helic1
09/04/2003WO2003073062A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
09/04/2003WO2003072831A1 Surface modification, linker attachment, and polymerization methods
09/04/2003WO2003072830A1 Magnetic nanomaterials and methods for detection of biological materials
09/04/2003WO2003072829A1 Nanostructures containing pna joining or functional elements
09/04/2003WO2003072826A1 Stain-directed molecular analysis for cancer prognosis and diagnosis
09/04/2003WO2003072824A1 Markers for predicting pathological conditions in haert failure and method of using the same
09/04/2003WO2003072821A2 Method and nucleic acids for the analysis of a colon cell proliferactive disorder
09/04/2003WO2003072820A2 Method and nucleic acids for the analysis of colon cell proliferative disorders
09/04/2003WO2003072812A2 Method and nucleic acids for the analysis of colorectal cell proliferative disorders
09/04/2003WO2003072806A2 Modification of bioassays for detection of antigen characteristic of bacteria that are causative of ear and respiratory infections in children
09/04/2003WO2003072804A2 Nanostructures containing pilin protein
09/04/2003WO2003072803A2 Nanostructures containing antibody assembly units
09/04/2003WO2003072801A2 Compositions and method for regulation of calcium-dependent signalling in brain
09/04/2003WO2003072799A2 Brother of the regulator of imprinted sites (boris)
09/04/2003WO2003072787A2 Method for detection of leptin receptor ligands
09/04/2003WO2003072782A1 Echinococcus antigen, gene encoding the same and method of diagnosing human hydatidosis
09/04/2003WO2003072779A1 Method of using pituitary-specific genes
09/04/2003WO2003072778A1 Method of examining allergic disease
09/04/2003WO2003072752A2 Improved substrate chemistry for protein immobilization on a rigid support
09/04/2003WO2003072747A2 COMPARATIVE MOLECULAR FIELD ANALYSIS (CoMFA) UTILIZING TOPOMERIC ALIGNMENT OF MOLECULAR FRAGMENTS
09/04/2003WO2003072746A2 Subtilisin carlsberg proteins with reduced immunogenicity
09/04/2003WO2003072740A2 Novel type-1 cytokine receptor glm-r
09/04/2003WO2003072732A2 Methods of making hypermutable cells using pmsr homologs
09/04/2003WO2003072723A2 Intracellular signaling molecules
09/04/2003WO2003072720A2 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
09/04/2003WO2003072719A2 Metapneumovirus strains and their use in vaccine formulations and as vector for expression of antigenic sequences
09/04/2003WO2003072710A2 Protein biomarkers that distinguish prostate cancer from non-malignant cells
09/04/2003WO2003072700A2 Androgen receptor overexpressing skeletal myoblasts
09/04/2003WO2003072698A2 Surface proteins of leptospira
09/04/2003WO2003072608A1 Anti-human tenascin monoclonal antibody
09/04/2003WO2003072600A2 Methods of screening molecular libraries for active molecules that restore the function of target proteins and peptides that restore the function of mutant p53
09/04/2003WO2003072596A2 Clustering conformational variants of molecules and methods of use thereof
09/04/2003WO2003072595A2 Methods and products based on oligomerization of stress proteins
09/04/2003WO2003072546A1 Novel coupling agents, the active intermediates and the conjugates thereof and the use of said conjugates in diagnostic methods
09/04/2003WO2003072543A2 Methods of preventing or treating brain ischemia or brain injury
09/04/2003WO2003072542A2 Interfacial biomaterials
09/04/2003WO2003072240A1 Apparatus for treatment of light-sensitive biopolymers
09/04/2003WO2003072134A1 Diagnostics and remedies for interstitial pneumonia
09/04/2003WO2003072131A1 Compositions, test kits and methods for detecting heliobacter pylori
09/04/2003WO2003072127A1 Method for drying water-borne materials
09/04/2003WO2003072126A2 Use of a fibroblast growth factor-binding protein for the treatment and diagnosis of diabetic wound healing problems
09/04/2003WO2003072125A1 Therapeutic and diagnostic targeting of cancers cells with tumor homing peptides
09/04/2003WO2003072122A2 Diagnostics and therapeutics for diseases associated with endothelial differentiation lysophosphatic acid g-protein-coupled receptor 7 (edg7)
09/04/2003WO2003072107A1 Substituted pyrimidinones and pyrimidinthiones
09/04/2003WO2003072106A2 Use of tyrosine kinase inhibitors for treating substance use disorders
09/04/2003WO2003072068A2 Targeted immunotherapy of acute lymphoblastic leukemia (all)
09/04/2003WO2003072065A2 Drug signatures
09/04/2003WO2003072060A2 Polypeptide formulation
09/04/2003WO2003072054A2 Custom ligand design for biomolecular filtration and purification for bioseperation
09/04/2003WO2003072037A2 High-level production of amyloid-beta peptides from imr-32 cells
09/04/2003WO2003072035A2 Compositions and methods for the treatment of immune related diseases
09/04/2003WO2003072023A2 Novel compositions and methods for the identification, assessment, prevention and therapy of ovarian cancer
09/04/2003WO2003072017A2 Macromolecular conjugates and processes for preparing same
09/04/2003WO2003072014A2 Minicell compositions and methods
09/04/2003WO2003071933A2 Novel compositions and methods for cancer
09/04/2003WO2003071927A2 Diagnostics and therapeutics for macular degeneration-related disorders